Loading Events

Join our online panel to hear from experts about the links between genetics and frontotemporal degeneration and other young onset dementias. Featuring Dr. Alison Goate from the Icahn School of Medicine at Mount Sinai, the speakers will share about recent developments in genetics research, and ways the public can get support if they are affected by these forms of dementia.

Register >

Dr. Alison Goate, Chair of the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai

Dr. Alison Goate is the Jean C and James W. Crystal Professor and Chair of the Dept. of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai (ISMMS). She has worked on the genetics of neurodegenerative diseases including Alzheimer’s disease (AD) and Frontotemporal Dementia (FTD) since 1987, and is the founding director of the Ronald M. Loeb Center for Alzheimer’s disease at ISMMS. She reported the first mutation to cause familial Alzheimer’s disease. Dr. Goate is also a leader in the study of late onset AD genetics using both GWAS and sequencing approaches. Her team demonstrated the enrichment of AD risk variants in microglial enhancers, regulatory elements that control gene expression in immune cells of the brain. She is now building upon these insights using genome-editing in induced pluripotent stem cells to understand the molecular mechanisms of disease and to develop novel therapeutics. Dr. Goate has received many awards for her research including the Potamkin Award from the American Academy of Neurology, the Khalid Iqbal Lifetime Achievement Award from the Alzheimer’s Association, the MetLife Award and the Rainwater Prize for Innovation in Neurodegeneration, and Hartwig Piepenbrock-DZNE Prize for Neurodegenerative disease research. She was elected a fellow of AAAS in 2012 and a fellow of the National Academy of Medicine in 2016.

Kim Jenny, Manager of Genetic Initiatives, Association for Frontotemporal Degeneration

Kim Jenny joined the Association for Frontotemporal Degeneration (AFTD) as the Manager of Genetic Initiatives in 2022. She comes to AFTD with over 20 years of clinical experience as a genetic counselor. Kim strives to ensure families have the education and resources needed to make well informed decisions about genetic testing. She also offers psychosocial support via support groups focused on specific areas of concern for families impacted by genetic FTD.

This program is a partnership between Alzheimer’s San Diego, the Association for Frontotemporal Degeneration, and For Their Thoughts Foundation.

Go to Top